Annual EPS
-$21.32
+$7.20+25.25%
December 31, 2022
Summary
- As of February 10, 2025, NBRV annual earnings per share is -$21.32, with the most recent change of +$7.20 (+25.25%) on December 31, 2022.
- During the last 3 years, NBRV annual EPS has risen by +$257.43 (+92.35%).
Performance
NBRV EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EPS
-$2.72
+$5.05+64.99%
March 31, 2023
Summary
- As of February 10, 2025, NBRV quarterly earnings per share is -$2.72, with the most recent change of +$5.05 (+64.99%) on March 31, 2023.
- Over the past year, NBRV quarterly EPS has increased by +$2.31 (+45.92%).
Performance
NBRV Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EPS
-$19.20
+$2.31+10.74%
March 31, 2023
Summary
- As of February 10, 2025, NBRV TTM earnings per share is -$19.20, with the most recent change of +$2.31 (+10.74%) on March 31, 2023.
- Over the past year, NBRV TTM EPS has increased by +$4.35 (+18.47%).
Performance
NBRV TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EPS Formula
EPS = Net Income - Preferred Dividends
Shares Outstanding
Net Income - Preferred Dividends
Shares Outstanding
Shares Outstanding
NBRV EPS Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +25.3% | +45.9% | +18.5% |
| 3 y3 years | +92.3% | +95.6% | +92.9% |
| 5 y5 years | +96.6% | +97.0% | +93.1% |
NBRV EPS Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +33.8% | at high | +185.7% | at high | +65.5% |
| 5 y | 5-year | at high | +1207.5% | at high | +2565.4% | at high | +1358.3% |
| alltime | all time | -116.3% | +5528.5% | at high | +8172.1% | at high | +3259.4% |
Nabriva Therapeutics EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$2.72(-65.0%) | -$19.20(-10.7%) |
| Dec 2022 | -$21.32(-25.2%) | -$7.77(+84.6%) | -$21.51(+9.0%) |
| Sep 2022 | - | -$4.21(-6.4%) | -$19.74(-5.1%) |
| Jun 2022 | - | -$4.50(-10.5%) | -$20.80(-11.7%) |
| Mar 2022 | - | -$5.03(-16.2%) | -$23.55(-25.9%) |
| Dec 2021 | -$28.52(-78.9%) | -$6.00(+13.9%) | -$31.77(-40.6%) |
| Sep 2021 | - | -$5.27(-27.3%) | -$53.52(-24.4%) |
| Jun 2021 | - | -$7.25(-45.3%) | -$70.75(-27.6%) |
| Mar 2021 | - | -$13.25(-52.3%) | -$97.75(-33.0%) |
| Dec 2020 | -$135.23(-51.5%) | -$27.75(+23.3%) | -$146.00(-23.5%) |
| Sep 2020 | - | -$22.50(-34.3%) | -$190.75(-16.4%) |
| Jun 2020 | - | -$34.25(-44.3%) | -$228.25(-15.1%) |
| Mar 2020 | - | -$61.50(-15.2%) | -$269.00(-3.9%) |
| Dec 2019 | -$278.75(-50.7%) | -$72.50(+20.8%) | -$280.00(-9.7%) |
| Sep 2019 | - | -$60.00(-20.0%) | -$310.00(-34.7%) |
| Jun 2019 | - | -$75.00(+3.4%) | -$475.00(-6.9%) |
| Mar 2019 | - | -$72.50(-29.3%) | -$510.00(-3.3%) |
| Dec 2018 | -$565.00 | -$102.50(-54.4%) | -$527.50(-8.3%) |
| Sep 2018 | - | -$225.00(+104.5%) | -$575.00(+5.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2018 | - | -$110.00(+22.2%) | -$547.50(-4.4%) |
| Mar 2018 | - | -$90.00(-40.0%) | -$572.50(-8.0%) |
| Dec 2017 | -$622.50(-2.7%) | -$150.00(-24.1%) | -$622.50(-3.5%) |
| Sep 2017 | - | -$197.50(+46.3%) | -$645.00(+5.3%) |
| Jun 2017 | - | -$135.00(-3.6%) | -$612.50(-1.2%) |
| Mar 2017 | - | -$140.00(-18.8%) | -$620.00(-3.2%) |
| Dec 2016 | -$640.00(-46.7%) | -$172.50(+4.5%) | -$640.50(+33.2%) |
| Sep 2016 | - | -$165.00(+15.8%) | -$480.75(-3.4%) |
| Jun 2016 | - | -$142.50(-11.2%) | -$497.50(+38.8%) |
| Mar 2016 | - | -$160.50(+1158.4%) | -$358.53(+24.7%) |
| Dec 2015 | -$1200.00(+805.9%) | -$12.75(-93.0%) | -$287.45(-8.5%) |
| Sep 2015 | - | -$181.75(+5061.6%) | -$314.12(+80.8%) |
| Jun 2015 | - | -$3.52(-96.1%) | -$173.77(-8.7%) |
| Mar 2015 | - | -$89.43(+126.9%) | -$190.30(+43.7%) |
| Dec 2014 | -$132.46(-201.2%) | -$39.42(-4.8%) | -$132.46(+42.4%) |
| Sep 2014 | - | -$41.40(+106.4%) | -$93.04(+80.2%) |
| Jun 2014 | - | -$20.06(-36.5%) | -$51.64(+63.5%) |
| Mar 2014 | - | -$31.58 | -$31.58 |
| Dec 2013 | $130.92 | - | - |
FAQ
- What is Nabriva Therapeutics annual earnings per share?
- What is the all time high annual EPS for Nabriva Therapeutics?
- What is Nabriva Therapeutics annual EPS year-on-year change?
- What is Nabriva Therapeutics quarterly earnings per share?
- What is the all time high quarterly EPS for Nabriva Therapeutics?
- What is Nabriva Therapeutics quarterly EPS year-on-year change?
- What is Nabriva Therapeutics TTM earnings per share?
- What is the all time high TTM EPS for Nabriva Therapeutics?
- What is Nabriva Therapeutics TTM EPS year-on-year change?
What is Nabriva Therapeutics annual earnings per share?
The current annual EPS of NBRV is -$21.32
What is the all time high annual EPS for Nabriva Therapeutics?
Nabriva Therapeutics all-time high annual earnings per share is $130.92
What is Nabriva Therapeutics annual EPS year-on-year change?
Over the past year, NBRV annual earnings per share has changed by +$7.20 (+25.25%)
What is Nabriva Therapeutics quarterly earnings per share?
The current quarterly EPS of NBRV is -$2.72
What is the all time high quarterly EPS for Nabriva Therapeutics?
Nabriva Therapeutics all-time high quarterly earnings per share is -$2.72
What is Nabriva Therapeutics quarterly EPS year-on-year change?
Over the past year, NBRV quarterly earnings per share has changed by +$2.31 (+45.92%)
What is Nabriva Therapeutics TTM earnings per share?
The current TTM EPS of NBRV is -$19.20
What is the all time high TTM EPS for Nabriva Therapeutics?
Nabriva Therapeutics all-time high TTM earnings per share is -$19.20
What is Nabriva Therapeutics TTM EPS year-on-year change?
Over the past year, NBRV TTM earnings per share has changed by +$4.35 (+18.47%)